Demographic and Clinical Factors Associated With Health-Related Quality-of-Life Profiles Among Prostate Cancer Survivors
- PMID: 38466917
- PMCID: PMC11656651
- DOI: 10.1200/OP.24.00076
Demographic and Clinical Factors Associated With Health-Related Quality-of-Life Profiles Among Prostate Cancer Survivors
Abstract
Purpose: Our purpose was to describe the prevalence and predictors of symptom and function clusters related to physical, emotional, and social components of general health-related quality of life (HRQOL) in a population-based sample of prostate cancer (PCa) survivors.
Methods: Participants (N = 1,162) completed a baseline survey at a median of 9 months after diagnosis to ascertain the co-occurrence of eight symptom and functional domains that are common across all cancers and not treatment-specific. We used latent profile analysis (LPA) to identify subgroup profiles of survivors with low, moderate, or high HRQOL levels. Multinomial logistic regression models were used to identify clinical and sociodemographic factors associated with survivors' membership in the low versus moderate or high HRQOL profile.
Results: The LPA identified 16% of survivors who were categorized in the low HRQOL profile at baseline, indicative of the highest symptom burden and lowest functioning. Factors related to survivors' membership in the low versus higher HRQOL profile groups included less than age 65 years at diagnosis, identifying as non-Hispanic Black race, not working, being a former versus never smoker, systemic therapy, less companionship, more comorbidities, lower health care financial well-being, or less spirituality. Several factors remained associated with remaining in the low versus higher HRQOL profiles on the follow-up survey (n = 699), including younger age, Black race, comorbidity, and lower financial and spiritual well-being.
Conclusion: About one of six PCa survivors experienced elevated physical and psychosocial symptoms that were independent of local curative therapy, but with younger age, race, comorbidity, and lower financial and spiritual well-being as stable risk factors for poor HRQOL over time.
Conflict of interest statement
The opinions and assertions expressed herein are those of the author(s) and do not reflect the official policy or position of the Uniformed Services University of the Health Sciences or the Department of Defense.
Declarations
Figures

Similar articles
-
Exercise interventions on health-related quality of life for people with cancer during active treatment.Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD008465. doi: 10.1002/14651858.CD008465.pub2. Cochrane Database Syst Rev. 2012. PMID: 22895974 Free PMC article.
-
Exercise interventions on health-related quality of life for cancer survivors.Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD007566. doi: 10.1002/14651858.CD007566.pub2. Cochrane Database Syst Rev. 2012. PMID: 22895961 Free PMC article.
-
Health-related quality of life among long-term (≥5 years) prostate cancer survivors by primary intervention: a systematic review.Health Qual Life Outcomes. 2018 Jan 23;16(1):22. doi: 10.1186/s12955-017-0836-0. Health Qual Life Outcomes. 2018. PMID: 29361950 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Interventions for promoting habitual exercise in people living with and beyond cancer.Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3. Cochrane Database Syst Rev. 2018. PMID: 30229557 Free PMC article.
Cited by
-
Cancer survivor preferences on the timing and content of interventions to mitigate financial toxicity associated with cancer treatment.Support Care Cancer. 2024 Nov 8;32(12):778. doi: 10.1007/s00520-024-08983-5. Support Care Cancer. 2024. PMID: 39511025
-
Shared decision making in routine oncology appointments with Black patients with lung cancer.Support Care Cancer. 2025 Mar 5;33(4):250. doi: 10.1007/s00520-025-09300-4. Support Care Cancer. 2025. PMID: 40042631
-
Chronic Prostate Cancer-Related Symptoms and Toxicities Following Stereotactic Body Radiation Therapy: Implications for Future Radionuclide Therapy.Cureus. 2025 May 29;17(5):e85034. doi: 10.7759/cureus.85034. eCollection 2025 May. Cureus. 2025. PMID: 40585713 Free PMC article.
References
-
- Office of Cancer Survivorship | Division of Cancer Control and Population Sciences (DCCPS) [Internet][cited 2023 Feb 18] Available from: https://cancercontrol.cancer.gov/ocs
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous